Literature DB >> 4916788

Immunosuppressants in the treatment of pemphigus.

S Jablonska, T Chorzelski, M Blaszczyk.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4916788     DOI: 10.1111/j.1365-2133.1970.tb15707.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

Review 1.  Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

Authors:  A Anstey
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

Review 2.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Novel therapies for pemphigus vulgaris: an overview.

Authors:  Oliver A Perez; Timothy Patton
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.

Authors:  A Medved; I Maxwell
Journal:  Can Med Assoc J       Date:  1974-08-03       Impact factor: 8.262

5.  A randomised clinical trial to assess the adjuvant potential of methotrexate to corticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris.

Authors:  Khimit Jain; Vishal Thakur; Sanjeev Handa; Neha Thakur; Naresh Sachdeva; Rahul Mahajan; Dipankar De
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

Review 6.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.